CDC37 and prostate carcinoma: We showed that MZF1 binds to sites in the CDC37 promoter and strongly activates transcription; moreover, MZF1 expression is tightly correlated with CDC37 levels in clinical prostate cancer (Figure 1 and Figure 2, Table 1).